Affordable Access

deepdyve-link deepdyve-link
Publisher Website

The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.

Authors
Type
Published Article
Journal
The Prostate
1097-0045
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
68
Issue
16
Pages
1798–1805
Identifiers
DOI: 10.1002/pros.20842
PMID: 18780294
Source
Medline
License
Unknown

Abstract

The SRD5A2 leucine isoform appears to be acting in a dose-dependent manner as a significant disease-modifying factor in young men diagnosed with PCa.

Statistics

Seen <100 times